Evaluate ORIC stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ORIC? | Glauxie AI

Q: What are the risks of investing in ORIC?

ORIC Pharmaceuticals, Inc. (ORIC) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jacob Chacko. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include... Employees: 200,000.

Q: How much debt does ORIC have?

Review ORIC total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ORIC a good long-term investment?

Evaluate ORIC as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ORIC?

🦉

ORIC Pharmaceuticals, Inc. (ORIC)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJacob Chacko

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to...

Key Executives

Name	Title
Charles L. Sawyers	Founder & Member of Scientific Advisory Board
Christian V. Kuhlen	General Counsel
Daniel Iazzetti	Vice President & Head of People
Dominic G. Piscitelli	Chief Financial Officer
Edna Chow Maneval	Executive Vice President of Clinical Development
Jacob Chacko	President, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ORIC Profile Financials

Is ORIC stock safe? How much debt does ORIC have? Is ORIC a good long-term investment?